Department of Health and Social Care written question – answered on 23rd April 2018.

Alert me about debates like this

Photo of Tim Farron Tim Farron Liberal Democrat Spokesperson (Environment, Food and Rural Affairs)

To ask the Secretary of State for Health and Social Care, what steps his Department is taking to ensure that patients can promptly access drugs if the UK is no longer a member of the European Medicines Agency during any transition period after the UK leaves the EU.

Photo of Jackie Doyle-Price Jackie Doyle-Price The Parliamentary Under-Secretary for Health and Social Care

During the implementation period, the United Kingdom will no longer be a Member State of the European Union, but market access will continue on current terms. We will continue to have access to drugs at the same time as countries within the EU, and the UK will continue to participate in and have access to European Medicines Agency (EMA).

In regard to the future relationship, the Prime Minister's Mansion House speech outlined that we will also explore the terms on which the UK could remain part of the EMA. While it would not be appropriate to pre-judge the outcome of the negotiations we will discuss with the EU and Member States how best to continue cooperation in medicines regulation.

Does this answer the above question?

Yes1 person thinks so

No3 people think not

Would you like to ask a question like this yourself? Use our Freedom of Information site.